China’s antitrust authority has paused its review of Broadcom’s (NASDAQ:AVGO) planned $61 billion purchase of VMware (NYSE:VMW) as the regulator has advanced remedy talks with the parties on the transaction.
China’s State Administration for Market Regulation is likely to impose behavioral remedies on the deal, according to a Dealreporter item on Wednesday. It’s not unusual for the SAMR to pause the review when a transaction enters the…